877PTY Toric IOL for Corneal Astigmatism

Study start date: April 16, 2024

Inclusion Criteria: * adult patients (18 years old and older); * cataract and/or corneal astigmatism diagnosis; * indication for cataract surgery or refractive lens exchange; * recommended cylinder correction with toric IOL with cylinder power ≥1.0D; * clear intraocular media other than cataract; * signed informed consent form; Exclusion Criteria: * irregular astigmatism; * patients who are not targeted to emmetropia (predicted residual spherical equivalent and/or astigmatism is out of the range of ±0.5D and ±0.38D respectively); * any retinopathy or maculopathy that affects the vision; * iris neovascularization; * congenital eye abnormality affecting visual performance; * advanced glaucoma; * pseudoexfoliation syndrome affecting IOL stability; * amblyopia; * uveitis; * retinal detachment; * prior ocular surgery in personal medical history; * irregular corneal curvature or corneal diseases affecting visual performance; * high myopia (axial length ≥ 26,5 mm); * inadequate visualization of the fundus on preoperative examination; * dilated pupil size not large enough to visualize toric IOL axis markings postoperatively based on the Investigator's decision; * eye trauma in medical history; * instability of keratometry or biometry measurements; * prior corneal refractive surgery such as LASIK, PRK, or SMILE; * patients deemed ineligible by the investigator because of any systemic disease or treatment; * pregnancy or lactation; * current use of systemic steroids or external ophthalmic drugs; * concurrent participation in another drug or device investigation. Intraoperative exclusions: the presence of the following intraoperative exclusion criteria will lead to the exclusion of the subject: \- Any unexpected or serious intraoperative complication that makes IOL implantation impossible or results in implantation of another type of IOL that is outside the scope of this clinical trial.